Extended Mortality Results for Ovarian Cancer Screening in the PLCO Trial with Median 15 Years Follow-up

BACKGROUND: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial originally reported no mortality benefit of ovarian cancer screening after a median of 12.4 years of follow-up. The UKCTOCS screening trial failed to show a statistically significant mortality reduction in the prima...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Gynecol Oncol
Main Authors: Pinsky, Paul F., Yu, Kelly, Kramer, Barnett S., Black, Amanda, Buys, Saundra S., Partridge, Edward, Gohagan, John, Berg, Christine D., Prorok, Philip C.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5077651/
https://ncbi.nlm.nih.gov/pubmed/27615399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.08.334
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki